NCI and all five cooperative groups that make up the National Clinical Trials Network have launched a large-scale precision medicine initiative that will match cancer patients with early-phase clinical trials testing novel drug combinations that target specific tumor alterations.
Kate Choi grew up hearing conversations about skin cancer. Her grandparents had it, as did her cousins.
